Loading organizations...

§ Venture Capital · 65 Gresham Street, 6th Floor, London, EC2V 7NQ, United Kingdom
Open-ended fund investing in UK equities for retail & institutional investors, focused on income & capital growth.
CF Woodford Equity Income Fund operates as an open-ended investment company, meticulously structured to provide investors with both a reasonable level of income and capital appreciation. The fund's strategy involves primarily deploying capital into a concentrated portfolio of UK-listed equities, alongside selective investments in unquoted companies and overseas entities, guided by a distinctive long-term, value-oriented investment philosophy. Its approach prioritizes fundamental analysis and contrarian positioning, aiming to identify undervalued businesses overlooked by the broader market.
The fund was established in June 2014 by Neil Woodford, building on his esteemed reputation as a leading fund manager. Woodford launched his eponymous investment management firm with the core insight of offering transparent, long-horizon investment strategies to a broad investor base. His pedigree, honed over two decades at Invesco Perpetual, underscored the firm’s commitment to disciplined, research-driven portfolio management.
Serving a diverse base of retail and institutional clients, the fund’s vision centered on democratizing access to expert-led investment management. It sought to deliver consistent long-term returns by focusing on companies with sustainable competitive advantages, thereby empowering investors to achieve their financial objectives through a rigorously managed equity income vehicle.
CF Woodford Equity Income Fund has 1 tracked investment across 1 company. The latest tracked deal is $100.9M Series C in Kymab in November 2016.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 24, 2016 | Kymab | $100.9M Series C | Simone Song | Bill & Melinda Gates Foundation, Malin Corporation, Shenzhen Hepalink Pharmaceutical, Woodford Patient Capital Trust |